ARR Growth Trajectory
Jan 2023 – May 2025MRR Waterfall
April → May 2025Geographic Mix
47 Hospitals · 4 CountriesUnit Economics Trend
Q1 2024 – Q1 2025Clinical Outcomes — Readmission Reduction
8 Key Hospitals · Avg 34% Reduction5-Year Financial Projections
FY25 Actual · FY26–FY29 ForecastSales Pipeline Funnel
May 2025Customer Health by Tier
NPS · NRR · Risk
TierCountNPSNRRRisk
Enterprise
8
91
138%
None
Professional
28
87
122%
1 acct
Starter
11
82
108%
None
Total
47
87
124%
1 acct
ZERO CHURN SINCE FOUNDING — 47/47 RETAINED
Competitive Benchmark — AUC-ROC Performance
NexusGuard vs. Industry ModelsGeographic Expansion — Current vs. FY26 Target
109 hospitals targeted across 6 countriesCompany Milestones & Roadmap
2023 – 2026Jan 2023
Company Founded
Arjun Mehta & Priya Nair · Pune, India · First 2 hospital pilots
Jun 2023
Seed Round Closed · $1.5M
9 hospitals · $540K ARR · NexusGuard v1.0 launched
Dec 2023
$1.6M ARR · 26 Hospitals
Thailand expansion · Bumrungrad Hospital signed · AUC 0.891 validated
Dec 2024
$3.96M ARR · 44 Hospitals
Singapore entry · Malaysia expansion · Series A process begins
May 2025 ← NOW
Series A Closed · $10M · $4.8M ARR
Accel India $6M + Blume Ventures $4M · 47 hospitals · Lancet paper accepted
Q3 2025
NexusGuard ICU GA · UAE Commercial Launch
ICU deterioration model · Dubai office · Arabic NLP · 3 UAE hospitals live
Dec 2025
$12M ARR Target · 109 Hospitals
6 countries · 120 headcount · EBITDA breakeven approaching
2026
Series B · EU Market Entry · $24M ARR
CE Mark · Saudi Arabia · Pharma data platform · EBITDA positive